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Innate immune defences are essential for the control of virus infection and are triggered through host recognition of viral macromolecular motifs known as pathogen-associated molecular patterns (PAMPs) 1 . Hepatitis C virus (HCV) is an RNA virus that replicates in the liver, and infects 200 million people worldwide 2 . Infection is regulated by hepatic immune defences triggered by the cellular RIG-I helicase. RIG-I binds PAMP RNA and signals interferon regulatory factor 3 activation to induce the expression of interferon-a/b and antiviral/interferon-stimulated genes (ISGs) that limit infection [3] [4] [5] [6] [7] [8] [9] [10] . Here we identify the polyuridine motif of the HCV genome 39 non-translated region and its replication intermediate as the PAMP substrate of RIG-I, and show that this and similar homopolyuridine or homopolyriboadenine motifs present in the genomes of RNA viruses are the chief feature of RIG-I recognition and immune triggering in human and murine cells 8 . 59 terminal triphosphate on the PAMP RNA was necessary but not sufficient for RIG-I binding, which was primarily dependent on homopolymeric ribonucleotide composition, linear structure and length. The HCV PAMP RNA stimulated RIG-I-dependent signalling to induce a hepatic innate immune response in vivo, and triggered interferon and ISG expression to suppress HCV infection in vitro. These results provide a conceptual advance by defining specific homopolymeric RNA motifs within the genome of HCV and other RNA viruses as the PAMP substrate of RIG-I, and demonstrate immunogenic features of the PAMP-RIG-I interaction that could be used as an immune adjuvant for vaccine and immunotherapy approaches.
To determine the nature of the HCV PAMP RNA, we conducted a functional screen to identify HCV PAMP RNA motifs. We assessed the ability of 1 mg of HCV genome RNA or contiguous subgenomic segments to trigger the interferon (IFN)-b promoter in transfected human Huh7 cells. The full-length HCV genome triggered innate immune signalling to induce the IFN-b promoter (Fig. 1a) . Two regions of the HCV RNA, encoding nucleotides 2406-3256 and 8872-9616, significantly induced the IFN-b promoter (Fig. 1b) , with signalling activity respectively localized to nucleotides 2406-2696 of the open reading frame and 9389-9619 encoding the 39 non-translated region (NTR) (Fig. 1c) . Deletion of the 39 NTR but not nucleotides 2408-2663 from the HCV genome significantly attenuated promoter signalling (Fig. 1d) . PAMP motifs are typically conserved among strains of a pathogen 1 , and sequence comparison of multiple HCV genomes revealed global variability within nucleotides 2406-2696 among virus strains, but nucleotides 9389-9616 encoded motifs of high conservation ( Supplementary Fig. 1 ) 11 . Thus, the viral 39 NTR might encode HCV PAMP motifs that trigger innate immune signalling in the host cell.
The HCV 39 NTR is comprised of three regions: a variable region with potential secondary structure; a non-structured poly-U/UC region containing polyuridine with interspersed ribocytidine; and the terminal X region containing three conserved stem-loop structures (Fig. 1e ) 12 . We evaluated the ability of RNA encoding the HCV 39 NTR or each of its regions to trigger intracellular signalling. Because HCV RNA replicates through a negative-sense replication intermediate 2, 13 , we included analyses of signalling triggered by the replication intermediate counterparts of the 39 NTR and its composite regions. RNA encoding the genomic or replication intermediate poly-U/UC region was sufficient to trigger signalling to the IFN-b promoter, but neither the variable nor X region genomic and replication intermediate RNA induced promoter signalling (Fig. 1f) . The HCV 39 NTR and poly-U/UC, but not the X region, RNA motifs similarly stimulated signalling when introduced into HeLa cells ( Supplementary Fig. 2a ). Moreover, in Huh7 cells genomic or replication intermediate 39 NTR and poly-U/UC RNA each stimulated the formation of active interferon regulatory factor 3 (IRF3) dimers and expression of ISG56, an IRF3 target gene 3 , but X region RNA failed to trigger either (Fig. 1g) . The poly-U/UC, but not X region, RNA formed a stable complex with purified RIG-I (Fig. 1h ). These results define the 100-nucleotide poly-U/UC region of the HCV genome and replication intermediate RNA as the HCV PAMP motif and potential substrate of RIG-I signalling. We also found that the entire HCV 59 NTR, which contains four major stem-loop structures comprising the viral internal ribosome entry site 14 , was only a weak inducer of promoter signalling. However, prior treatment of Huh7 cells with IFN-b to increase RIG-I levels 4 rendered them responsive to signalling triggered by the HCV 59 NTR or X region RNA ( Supplementary Fig. 3 ). Thus, double-stranded (ds)RNA regions of the HCV RNA are not potent PAMPs but may confer signalling during the IFN response.
To determine the role of RIG-I or other pathogen recognition receptor (PRR) pathways in HCV PAMP signalling, we first examined IFN-b promoter induction in Huh7.5 cells encoding non-functional RIG-I 4 . The cells were refractory to HCV RNA-induced signalling whereas their response was rescued and enhanced on overexpression of wild-type RIG-I (Fig. 2a) . MDA5 is a PRR related to RIG-I that binds to dsRNA 15 , whereas MyD88 and TRIF are essential adaptor proteins used by Toll-like receptor (TLR) 7/8 and TLR3, respectively, which are PRRs that recognize endosomal singlestranded poly-U RNA or dsRNA 1, 16 . We examined PAMP signalling in mouse embryo fibroblasts (MEFs) lacking RIG-I, MDA5, MyD88 or TRIF (Figs 2b-e, Supplementary Fig. 4 ). When introduced into RIG-I 2/2 MEFs the HCV RNAs did not trigger promoter activation, but 39 NTR and poly-U/UC RNA, but not X region RNA, stimulated signalling in wild-type, MDA5 2/2 , Myd88 2/2 or Trif 2/2 cells. In Huh7 cells, poly-U/UC RNA co-localized and mediated a specific interaction with RIG-I (Fig. 2f) . Thus, RIG-I is the essential PRR that signals the innate immune response triggered by HCV poly-U/UC RNA independently of MDA5-, MyD88-or TRIF-dependent PRR pathways.
RIG-I binds to PAMP RNA containing 59 terminal triphosphate (59ppp) through which the triphosphate end is proposed to anchor the RNA within charged residues of the RIG-I repressor domain, causing a conformation change to displace the repressor domain and release signalling autorepression [17] [18] [19] . Gel-shift assays revealed that 59ppp was required for poly-U/UC RNA binding by RIG-I but did not mediate stable RIG-I interaction with X region RNA (Fig. 3a) . RNA, and supported low-level promoter induction triggered by X region RNA in IFN-treated cells (Fig. 3b) . Because X region RNA failed to form a stable complex with RIG-I and only weakly triggered signalling, stable RIG-I-RNA interaction is probably required to release RIG-I autorepression. We therefore conducted limited trypsin digestion analysis of purified RIG-I alone or bound to poly-U/UC or X region RNA containing 59ppp. This approach provides an assessment of RIG-I repressor domain displacement in response to PAMP RNA binding wherein the displaced repressor domain of signalling-active RIG-I presents as a protected 17-kDa fragment [17] [18] [19] . As shown in Fig. 3c , RIG-I binding of poly-U/UC but not X region RNA rendered the protected 17-kDa repressor domain fragment. These results demonstrate that 59ppp is necessary but not sufficient for RNA binding by RIG-I wherein the HCV poly-U/UC RNA directs stable interaction with RIG-I in a 59ppp-dependent manner that confers signalling activation. We used 59ppp RNA in all further experiments.
The HCV polyU/UC region is a flexible motif among HCV strains and is essential for viral replication 13 . In the HCV genotype 1b strain used in these experiments, the poly-U/UC region is comprised of 100 nucleotides containing 78% uridine and 22% ribocytosine ( Supplementary Fig. 5 ). A reduction of length through progressive 39 truncation to 50 nucleotides or fewer attenuated signalling in Huh7 cells (Fig. 3d) , consistent with reduced RIG-I binding of short RNAs 20 . Replacement of ribocytosine with riboguanine (poly-U/UG) had no impact on PAMP signalling, but progressive replacement of uridine for riboguanine to below 80% uridine or 100% polyriboguanine (poly-G) reduced or abrogated PAMP signalling (Fig. 3e) . Because the replication intermediate poly-U/UC RNA contains high polymeric riboadenine content, we also examined the impact of poly-A composition and length on RIG-I signalling. One-hundrednucleotide poly-A RNA and poly-U/UC RNA equally induced signalling to the IFN-b promoter, whereas reduced riboadenine content of the former through progressive nucleotide replacement to poly-G attenuated or ablated signalling (Fig. 3f) . In side-by-side analyses we found that poly-U/UC, poly-U/UG and poly-A RNA, but neither poly-C nor poly-G RNA, could trigger signalling to the IFN-b promoter in Huh7 (Fig. 3g) and HeLa cells (Supplementary Fig. 2b) . Truncation of the poly-A RNA to 50 nucleotides or fewer attenuated signalling to the IFN-b promoter to the same extent as truncation of poly-U/UC (Supplementary Fig. 2c ). Whereas poly-C and poly-G RNA bound negligibly to RIG-I, poly-U/UC, poly-U/UG and poly-A RNA formed a stable complex with RIG-I ( Supplementary Fig. 5e ) that released the RIG-I repressor domain to the active conformation (Fig. 3h) . These results define polymeric uridine or riboadenine motifs of 50 nucleotides or greater-including the PU/UC and replication intermediate PU/UC motif of HCV-as the PAMP signature within 59ppp RNA that is efficiently recognized by RIG-I to trigger the immune response.
To determine whether RIG-I recognition of the HCV poly-U/UC PAMP motif triggers hepatic innate immune defences in vivo, we conducted RNA signalling analysis in wild-type and RIG-I 2/2 mice. Intravenous administration of full-length HCV 1b genome stimulated hepatic Ifnb messenger RNA expression within 8 h in wild-type mice but not in RIG-I 2/2 mice, and signalling was significantly attenuated on deletion of the HCV 39 NTR (Fig. 4a) . Moreover, the poly-U/UC RNA motif, but not the X region RNA motif, was sufficient to trigger the hepatic IFN-b expression in wild-type but not in RIG-I 2/2 mice. In time course studies we found that the poly-U/UC RNA motif We confirmed the 17-kDa fragment as the RIG-I repressor domain by immunoblot analysis of the digestion products using an antiserum specific to the RIG-I carboxy terminus (not shown), as previously described 17 . Asterisks indicate significant difference (P , 0.01) as determined by Student's t-test.
induced a peak of hepatic Ifnb mRNA expression and IFN-b serum levels at 8 h after injection in wild-type mice (Fig. 4b, c) . This response was associated with induced hepatic expression of RIG-I and ISG56 mRNA and tissue-wide expression of hepatic ISG54 (Fig. 4d-f) , similar to the hepatic response in HCV-infected patients 9, 10 . RIG-I 2/2 mice expressed only a low level of Ifnb and ISG56. The tissue-wide nature of hepatic ISG54 expression in wildtype mice suggests that paracrine signalling of IFN-b could have an important role in hepatic defences against HCV. To test this idea we measured HCV production in infected Huh7 cells that were treated with IFN-b or supernatants collected from cultures transfected with HCV poly-U/UC RNA, X-region RNA, or tRNA (control). Poly-U/ UC RNA triggered IFN-b expression in the transfected cells (data not shown), and only treatment with IFN-b or supernatant from the poly-U/UC-transfected cells induced a response that suppressed HCV infection (Fig. 4g, h) . Thus, the poly-U/UC RNA is an HCV genome PAMP that is necessary and sufficient to trigger RIG-I signalling of the hepatic innate immune response. The actions of RIG-I signalling can induce an antiviral response directly (Fig. 1g) , as well as through indirect, paracrine actions of IFN produced from HCV PAMP signalling (Fig. 4g, h) .
Our results provide new insights into the features of PAMP specificity of RIG-I wherein RNA virus genome sequences consisting of poly-U and respective replication intermediate poly-A motifs of length .50 nucleotides are the determinants that confer efficient RIG-I binding and signalling. 59ppp was necessary but not sufficient for stable binding of HCV PAMP RNA by RIG-I. In terms of the HCV genome, well defined internal RNA interactions of the 59 and 39 ends 21, 22 could provide 59ppp and PAMP motif proximity for stable RIG-I binding. The poly-U/UC motif is an essential determinant of HCV replication fitness 21 . Thus, as the virus must maintain this motif for its viability, the host takes advantage of this requirement and targets the poly-U/UC region as a discriminator of PAMP RNA through RIG-I interaction. Poly-U and/or poly-A motifs are present in localized regions in the genome of RNA viruses known to trigger RIG-I signalling (Supplementary Table 1 ) 5, 8, 19 . We found that 59ppp genomic poly-U/A-rich RNA motifs within the rabies virus leader sequence, Ebola virus 39 region, or the measles virus leader sequence each triggered signalling to the IFN-b promoter in Huh7 cells, but GC-rich RNA motifs from each viral genome did not trigger a significant response ( Supplementary Fig. 7a, b) . We also found that pppT3-63, Tri-GFP and EGFP 2 T7 RNAs, previously described as RIG-I substrates and comprised of 50% or fewer A/U nucleotides 5, 18, 23 , could induce only weak signalling to the IFN-b promoter compared to the poly-U/UC RNA . Thus, A/U composition and poly-U motifs are the major determinants of viral PAMP RNA recognition by RIG-I. Cellular RNAs also contain poly-U and poly-A motifs but mRNAs are typically capped and are bound by poly-A binding proteins 24 , whereas ribosomal RNAs are 'masked' as ribonucleoprotein complexes 25 . These features and the context of 59ppp with viral poly-U and poly-A motifs serve to identify self from non-self RNA by governing RIG-I recognition, wherein, non-self recognition of the HCV PAMP RNA triggers a hepatic innate immune response. These observations provide a possible explanation of why 25% or more of all HCV-exposed people clear acute infection 2 and why HCV needs to evade innate immunity through viral NS3/4A protease targeting of the RIG-I pathway 26, 27 . RIG-I substrates such as the poly-U/UC RNA or structurally similar compounds could provide therapeutic application as immune adjuvants similar to TLR agonists 28 , and offer innate immune stimulatory properties that may improve IFN-based therapy for HCV through paracrine immune actions that limit infection 2 .
METHODS SUMMARY
RNA. RNA constructs and quality control analysis are shown in Supplementary  Fig. 5 . 59ppp RNA was synthesized using the T7 Megascript kit (Ambion). Fulllength and subgenomic HCV RNA were produced from plasmid DNA or T7 promoter-linked PCR products generated from cloned HCV N (A gift from S. Lemon) or Con1 genome (HCV genotype-1b) 29 . 59OH RNAs were purchased from Fidelity Systems. RNA transfection was performed using 1 mg of RNA per 1 3 10 5 cells with the Transmessenger reagent (Qiagen). One microgram of RNA mass approximates to the following picomoles: full-length HCV 1b genome, HCV 1b D2408-2663 and HCV 1b D39 NTR, 0.4 pmol; HCV 1b subgenomic RNA constructs, 5 or 15 pmol; HCV genotype 1b (Con1) 59 NTR, 39 NTR (20 pmol) , and all other RNA constructs, 30-150 pmol. RNA concentrations in the transfection mix were 5-10 mg ml 21 . Additionally, in experiments to assess signalling induced by subgenomic HCV RNA, we also measured promoter expression triggered by equimolar amounts of RNA. RNA delivery was assessed as described in Supplementary Fig. 6 . mRNA expression was determined by quantitative polymerase chain reaction with reverse transcription assay. DNA oligonucleotides used in this study are described in Supplementary Table 2 . RNA signalling analysis. IFN-b promoter luciferase analyses of transfected cells were conducted as described 17 . Protein expression and the abundance of IRF3 dimer and monomeric forms in cells were determined by immunoblot analysis 17 . RIG-I purification and RNA binding analysis. Full-length RIG-I or RIG-I amino acids 1-228 (N-RIG) were expressed in Escherichia coli and purified. RIG-I-RNA complexes were assessed by gel-shift assay and SYBR green staining (Lonza). RIG-I activation/conformation shift was analysed using the limited trypsin digestion method 17 . FRET analysis of Cy3-poly-U/UC RNA interaction with YFP-RIG-I or YFP-DAI proteins was conducted using N-FRET on a Zeiss confocal microscope 30 . Serum IFN-b levels were measured by ELISA (PBL). Mice. Mice 15 were from S. Akira 15 and were transfected using lipid-based in vivo RNA transfection reagent (Altogen). Statistical analysis. Data were compared using the Student's t-test.
